Skip to main content

Table 3 Percent efficacy of afoxolaner against Demodex spp. according to the age of the dogs and the presence of specific lesions of demodectic pododermatitis

From: Efficacy of two formulations of afoxolaner (NexGard® and NexGard Spectra®) for the treatment of generalised demodicosis in dogs, in veterinary dermatology referral centers in Europe

 

Dog age

 

Wilcoxon Rank Sum test

 

< 18 months

> 18 months

Z-value

P-value

Efficacy (%) against Demodex spp. in the overall treated population (n)

98.6 (26)

92.1 (22)

375.5

0.018

Efficacy against Demodex spp. excluding demodectic pododermatitis (n)

98.6 (22)

95.7 (12)

153

0.230

  1. Abbreviation: n number of dogs